These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27983891)

  • 21. New Gene-Editing Tool Slowly Advances Into the Clinic.
    Jenks S
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117363
    [No Abstract]   [Full Text] [Related]  

  • 22. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First in vivo human genome editing trial.
    Nat Biotechnol; 2018 Jan; 36(1):5. PubMed ID: 29319687
    [No Abstract]   [Full Text] [Related]  

  • 24. National Academies relax stance on germline edits.
    Sheridan C
    Nat Biotechnol; 2017 Apr; 35(4):295-296. PubMed ID: 28398320
    [No Abstract]   [Full Text] [Related]  

  • 25. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.
    Lin J; Zhou Y; Liu J; Chen J; Chen W; Zhao S; Wu Z; Wu N
    J Cell Biochem; 2017 Oct; 118(10):3061-3071. PubMed ID: 28590031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Therapy 2017: Progress and Future Directions.
    Keeler AM; ElMallah MK; Flotte TR
    Clin Transl Sci; 2017 Jul; 10(4):242-248. PubMed ID: 28383804
    [No Abstract]   [Full Text] [Related]  

  • 27. The tsunami named CRISPR/Cas9.
    Chneiweiss H
    Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853
    [No Abstract]   [Full Text] [Related]  

  • 28. Genome editing: A breakthrough in life science and medicine.
    Hatada I; Horii T
    Endocr J; 2016; 63(2):105-10. PubMed ID: 26698412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic genome engineering via CRISPR-Cas systems.
    Moreno AM; Mali P
    Wiley Interdiscip Rev Syst Biol Med; 2017 Jul; 9(4):. PubMed ID: 28198142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
    Baylis F
    Clin Chem; 2018 Mar; 64(3):489-491. PubMed ID: 29490999
    [No Abstract]   [Full Text] [Related]  

  • 31. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakthrough Moments: Genome Editing and Organoids.
    Roper J; Yilmaz ÖH
    Cell Stem Cell; 2019 Jun; 24(6):841-842. PubMed ID: 31173713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically modified humans: the X-Men of scientific research.
    Straiton J
    Biotechniques; 2019 Jun; 66(6):249-252. PubMed ID: 31124711
    [No Abstract]   [Full Text] [Related]  

  • 35. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
    Merkert S; Martin U
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases.
    Kaur B; Perea-Gil I; Karakikes I
    Curr Cardiol Rep; 2018 Jun; 20(7):58. PubMed ID: 29860642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?
    Cathomen T; Schüle S; Schüßler-Lenz M; Abou-El-Enein M
    Trends Biotechnol; 2019 Feb; 37(2):120-123. PubMed ID: 30017092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point: Treating Human Genetic Disease One Base Pair at a Time: The Benefits of Gene Editing.
    Katsanis N
    Clin Chem; 2018 Mar; 64(3):486-488. PubMed ID: 29490998
    [No Abstract]   [Full Text] [Related]  

  • 40. [Gene editing technology and its recent progress in disease therapy].
    Niu XR; Yin SM; Chen X; Shao TT; Li DL
    Yi Chuan; 2019 Jul; 41(7):582-598. PubMed ID: 31307968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.